Julie Gerberding: Extermely fortunate to benefit from Ellen Sigal’s passionate leadership as a member of FNIH Board
Julie Gerberding, CEO of Foundation for the National Institutes of Health(NIH), shared a post on LinkedIn:
“FNIH is extermely fortunate to benefit from Ellen Sigal’s passionate leadership as a member of our FNIH Board. I am inspired by her lifetime commitment to ensuring that people diagnosed with cancer not only have access to excellent treatment, but also access to excellent caring as they negotiate their illness.
For those of us who are working hard to make sure that the promises of bioscience breakthroughs are available to everyone, her message is a sobering reminder that need to do much more and work much faster. Thank you, Ellen!”
Sudip Parikh, CEO and Executive Publisher Science Family of Journals at AAAS, shared this post, adding:
“Ellen Sigal founder of Friends of Cancer Research is a hero of mine. Read this post and you’ll see why.”
Read full article at the ASCO Post.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023